Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is This Dividend King a Screaming Buy?

TheMotleyFool

0 0

Johnson & Johnson (NYSE: JNJ) has been in business since 1886. The company has experienced significant success along the way. However, its share price has never been higher than the levels already achieved in the first few weeks of 2026.

CEO Joaquin Duato said in J&J's fourth-quarter update earlier this week that 2025 "kicked off a new era of accelerated growth" for the company. Is the healthcare stock a screaming buy now?

Make no mistake: Johnson & Johnson offers plenty of positives for investors. We can put the company's dividend near the top of the list.

Source Fool.com

Like: 0

JNJ

Share